Dear Editor, Adverse events are common during conventional invasive lung sampling procedures [1] and may be particularly detrimental in critically ill patients [2] . We sought to describe the feasibility, safety, and diagnostic accuracy of endobronchial ultrasound transbronchial needle aspiration (EBUS-TBNA) in the intensive care unit (ICU).
Between May 2011 and May 2015, nine consecutive patients with acute respiratory failure (ARF) and mediastinal or hilar involvement were selected from a prospective cohort [3] that comprehensively describes all EBUS-TBNA procedures in Tenon hospital, a tertiary university teaching hospital in Paris, France. EBUS-TBNA was performed using a 6.7-mm-outer-diameter, real-time, bronchoscope with a 7.5-MHz linear ultrasound transducer.
The patients' main characteristics are reported in Table 1 . Diagnosis remained pending in all patients, despite conventional diagnosis procedures: bronchial biopsy (n = 7), bronchial aspiration (n = 6), bronchoalveolar lavage (n = 5), thoracentesis (n = 4), transbronchial lung biopsy (TBLB, n = 2), CT-guided biopsy (n = 2), and open lung biopsy (OLB, n = 1). Noteworthy that EBUS-TBNA was promoted in four patients because of lifethreatening hemoptysis complicating bronchial (patients 2, 4, and 7) or percutaneous CT-guided lung (patient 6) biopsy. The severity of the underlying pulmonary disease (patients 1, 5, 8) and the accessibility of the paratracheal region (patient 9) also affected the intensivists' decision for performing EBUS. Four patients were mechanically ventilated at the time of the procedure: two had been intubated on ICU admission for ARF, the third was intubated for the procedure, and a laryngeal mask was used for the fourth. Among those four patients, three (patients 1, 6, and 8) met the Berlin definition of acute respiratory distress syndrome. The five remaining patients breathed spontaneously with supplemental oxygen and without need for non-invasive ventilation or high flow oxygen. A median of 5 [4] [5] [6] [7] [8] [9] punctures was performed per patient. When representative, aspirations were diagnostic in 93 % of the cases (38/41 representative aspirations). In six cases (patients 1, 2, 4, 5, 7, and 9), the rapid onsite evaluation (ROSE) of the cytological specimens provided quick diagnostic information leading to treatment adaptation in four (patients 1, 2, 4, and 9). Multiple sites and repeated punctures improved the diagnostic yield (patient 7, site 4R negative and site 10R positive). Altogether, EBUS-TBNA provided a reliable diagnosis in eight patients (89 %) without adverse events. The procedure did not provide a reliable diagnosis in only one patient (patient 6) because all samples were non-representative of the node structure.
To our knowledge, we report the first case series of the usefulness of EBUS-TBNA in ICU. EBUS-TBNA may offer a minimally invasive option to access the pathologic structures in real time and may be particularly safe even in patients with ARF or at high risk of bleeding. The diagnostic yield is high, approaching that of OLB The final diagnosis of exogenous lipoid pneumonia was made on the basis of anamnesis, the CT pattern, and the presence of oil phagocytosis in macrophages in the EBUS lymph nodes aspirations, secondarily confirmed by transbronchial lung biopsies in mechanically ventilated patients [4] , with exceptional accuracy in cases of diagnostic deadlock, so that EBUS-TBNA might be preferable to TBLB when the hila or mediastinum is involved. Note that four patients (particularly 3 and 7) benefited from a unique advantage of EBUS, owing to the accessibility for puncture sites 10, 11, and 12, which are unreachable by other invasive techniques. Finally, coupled with ROSE, cytological analysis may improve the quality of the samples [5] and provide a quick provisional diagnosis at the bedside, which can be particularly valuable in critical care situations. Further studies are needed to confirm these promising results.
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